ARTL
Artelo Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.76
-0.14 ▼ -3.59%
🌙 3월 13일 5:51 PM ET (한국 3/14 06:51)
$3.85
+0.09 ▲ +2.33%
| Index | - | P/E | - | EPS (ttm) | -47.93 | Insider Own | 0.47% | Shs Outstand | 0.00B | Perf Week | 9.94% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.00B | Perf Month | -5.76% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 4.64% | Short Float | 2.53% | Perf Quarter | -34.04% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 2.62% | Short Ratio | 0.7 | Perf Half Y | -74.53% |
| Sales | 0.00B | P/B | - | EPS next 5Y | - | ROA | -343.49% | Short Interest | 0.02M | Perf YTD | 2.73% |
| Book/sh | -1.89 | P/C | 4.43 | EPS past 3/5Y | 16.31% 35.6% | ROE | -1625.11% | 52W High | -95.62% ($85.80) | Perf Year | -78.03% |
| Cash/sh | 0.85 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 19.37% ($3.15) | Perf 3Y | -91.54% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -162.14% | Gross Margin | - | Volatility(W/M) | 17.9% 12.51% | Perf 5Y | -99.29% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.47 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.17 | EPS Q/Q | 70.51% | Profit Margin | - | RSI (14) | 46.8 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.17 | Sales Q/Q | - | SMA20 | 1.76% ($3.69) | Beta | 1 | Target Price | $54 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -11.48% ($4.25) | Rel Volume | 0.88 | Prev Close | $3.9 |
| Employees | 7 | LT Debt/Eq | - | EPS/Sales Surpr. | -41.4% - | SMA200 | -75.98% ($15.65) | Avg Volume(3M) | 0.03M | Price | $3.76 |
| IPO | 2017/11/14 | Option/Short | No/Yes | Trades | 331 | Volume | 22,255 | Change | -3.59% |
뉴스 로딩 중...